
|Articles|July 1, 2002
New test helps patients self-monitor for AMD lesions
Author(s)Lynda Charters
Tel Aviv, Israel-The macular computerized psychophysical test (MCPT)-a new test for monitoring patients with age-related macular degeneration (AMD)-seems to be an efficient method for self-detection of AMD-related lesions, according to Anat Loewenstein, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SparingVision completes PRODYGY trial patient dosing with SPVN06
2
Angiogenesis 2026: Continuous AI severity scoring could transform AMD monitoring
3
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
4
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
5




























